CAV1 and neoplasm: From the perspective of human cancer progression, Li et al (2003) showed that caveolin-1 overexpression was able to maintain activated AKT levels in human prostate cancer cells via inhibition of the tumour suppressor enzymes PP1 and PP2A, which dephosphorylate AKT at both Ser473 and The308.